Literature DB >> 24475904

Correlation between HIF-1α expression and breast cancer risk: a meta-analysis.

Guogui Sun1, Yadi Wang, Wanning Hu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24475904     DOI: 10.1111/tbj.12238

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  6 in total

Review 1.  Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews.

Authors:  Xueyao Wu; Xiaofan Zhang; Yu Hao; Jiayuan Li
Journal:  Breast Cancer       Date:  2020-11-25       Impact factor: 4.239

Review 2.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

3.  HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling.

Authors:  Sheng Chen; Min Zhang; Lili Xing; Yue Wang; Yongtao Xiao; Yeming Wu
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

4.  Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis.

Authors:  Hai-Yong Ren; Yin-Hua Zhang; Heng-Yuan Li; Tao Xie; Ling-Ling Sun; Ting Zhu; Sheng-Dong Wang; Zhao-Ming Ye
Journal:  Onco Targets Ther       Date:  2016-03-14       Impact factor: 4.147

Review 5.  Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer.

Authors:  Nikita Jinna; Padmashree Rida; Max Smart; Mark LaBarge; Tijana Jovanovic-Talisman; Rama Natarajan; Victoria Seewaldt
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

6.  Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.

Authors:  Carolina Méndez-Blanco; Paula Fernández-Palanca; Flavia Fondevila; Javier González-Gallego; José L Mauriz
Journal:  Ther Adv Med Oncol       Date:  2021-02-07       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.